| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |